Growth Factor Gene-Modified Mesenchymal Stem Cells in Tissue Regeneration.
Ontology highlight
ABSTRACT: There have been marked changes in the field of stem cell therapeutics in recent years, with many clinical trials having been conducted to date in an effort to treat myriad diseases. Mesenchymal stem cells (MSCs) are the cell type most frequently utilized in stem cell therapeutic and tissue regenerative strategies, and have been used with excellent safety to date. Unfortunately, these MSCs have limited ability to engraft and survive, reducing their clinical utility. MSCs are able to secrete growth factors that can support the regeneration of tissues, and engineering MSCs to express such growth factors can improve their survival, proliferation, differentiation, and tissue reconstructing abilities. As such, it is likely that such genetically modified MSCs may represent the next stage of regen
SUBMITTER: Nie WB
PROVIDER: S-EPMC7105364 | biostudies-literature | 2020
REPOSITORIES: biostudies-literature
ACCESS DATA